Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma.
Saved in:
| Title: | Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma. |
|---|---|
| Authors: | Miklja, Zachary1 (AUTHOR), Yadav, Viveka Nand1 (AUTHOR), Cartaxo, Rodrigo T1 (AUTHOR), Siada, Ruby1 (AUTHOR), Thomas, Chase C1 (AUTHOR), Cummings, Jessica R1 (AUTHOR), Mullan, Brendan1 (AUTHOR), Stallard, Stefanie1 (AUTHOR), Paul, Alyssa1 (AUTHOR), Bruzek, Amy K2 (AUTHOR), Wierzbicki, Kyle1 (AUTHOR), Yang, Tao3 (AUTHOR), Garcia, Taylor1 (AUTHOR), Wolfe, Ian1 (AUTHOR), Leonard, Marcia1 (AUTHOR), Robertson, Patricia L3 (AUTHOR), Garton, Hugh Jl2 (AUTHOR), Wahl, Daniel R4 (AUTHOR), Parmar, Hemant5 (AUTHOR), Sarkaria, Jann N6 (AUTHOR) |
| Source: | Journal of Clinical Investigation. Oct2020, Vol. 130 Issue 10, p5313-5325. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
